Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia

Posaconazole tablets, a new oral formulation of posaconazole, can be effective when given as antifungal prophylaxis to neutropenic patients at high risk for invasive fungal infection (e.g., those with acute myelogenous leukemia or myelodysplastic syndrome). Such effectiveness might be specifically i...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Duarte, Rafael F., López-Jiménez, Javier, Cornely, Oliver A., Laverdiere, Michel, Helfgott, David, Haider, Shariq, Chandrasekar, Pranatharthi, Langston, Amelia, Perfect, John, Ma, Lei, van Iersel, Marlou L. P. S., Connelly, Nancy, Kartsonis, Nicholas, Waskin, Hetty
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2014
Предметы:
Clinical Therapeutics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4187965/
https://ncbi.nlm.nih.gov/pubmed/25049247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03050-14
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы